BIO-GABAPENTIN

biomed pharma🇨🇦 Health Canada

Approval Id: dab001e993d189cf
Drug Approval Canada Name: BIO-GABAPENTIN
Product Name: BIO-GABAPENTIN
Status: Cancelled Post Market
Status Date: 2022-07-19
Original Market Date: 2017-06-21
Din: 02450151
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N02BF01 GABAPENTIN
Atc Name: n 02 bf 01
Aig Number: 0125929003
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

GABAPENTIN

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

dab001e993d189cf

Type

Standard